Benefits and limitations of mass breast screening. The natural history of breast cancer;Bénéfices et limites du dépistage de masse. L'histoire naturelle du cancer du sein

Bulletin de l'Academie Nationale de Medecine

Volumn 182, Issue 8, 1998, Pages 1593-1611

  Tubiana, Maurice ^a  

^a Laboratoire d'Excellence Inflamex   (France)

Author keywords

Breast Neoplasms; Europe; France; Mass Screening

Indexed keywords

ADULT; AGE; ARTICLE; BIOPSY; BREAST; BREAST TUMOR; COMPARATIVE STUDY; EUROPE; EVALUATION; FEMALE; FRANCE; HUMAN; LABORATORY DIAGNOSIS; LYMPH NODE METASTASIS; MAMMOGRAPHY; MASS SCREENING; METASTASIS; MIDDLE AGED; PATHOLOGY; PSYCHOLOGICAL ASPECT; RADIOGRAPHY; STANDARD;

ADULT; AGE FACTORS; BIOPSY; BREAST; BREAST NEOPLASMS; EUROPE; EVALUATION STUDIES; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FRANCE; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASM METASTASIS;

EID: 2442693176     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. TUBIANA M., CHAUVEL P., RENAUD A., MALAISE E.P. - Vitesse de croissance et histoire naturelle du cancer du sein. Bull Cancer (Paris), 1975, 62, 341-58.
2. KOSCIELNY S., TUBIANA M., LE M.G. et al. - Breast cancer : relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer, 1984, 49, 709-15.
3. TUBIANA M., KOSCIELNY S. - Natural history of human breast cancer - recent data and clinical implications. Breast Cancer Res, 1991, 18, 125-40.
4. TUBIANA M., KOSCIELNY S. - The rationale for early diagnosis of cancer. The example of breast cancer. Acta Oncologica (submitted for publication).
5. TABAR L., FAGERBERG G., DAY N.E. et al. - Breast cancer treatment and natural history : new insights from results of screening. Lancet, 1992, 339, 412-4.
6. SLACK N.H., BLUMENSON L.E., BROSS I.D.J. - Therapeutic implications of a mathematical model characterizing the course of breast cancer. Cancer, 1969, 24, 960-71.
7. TUBIANA M., COURDI A. - Cell proliferation kinetics in human solid tumors : relation to probability of metastatic dissemination and long term survival. Radiother Oncol, 1989, 15, 1-18.
8. TUBIANA M., PEJOVIC M.H., KOSCIELNY S., CHAVAUDRA N., MALAISE E. - Growth rate, kinetics of tumor cell proliferation, and long-term outcome in human breast cancer. Int J Cancer, 1989, 44, 17-22.
9. CHARBIT A., MALAISE E.P., TUBIANA M. - Relation between the pathological nature and the growth rate of human tumors. Eur J Cancer, 1971, 7, 307-15.
10. KOSCIELNY S., TUBIANA M., VALLERON A.J. - A simulation model of the natural history of human breast cancer. Br J Cancer, 1985, 58 515-24.
11. EISINGER F., STOPPA-LYONNET D., LONGEY H. et al. - Germ line mutation at BRCA-1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res, 1996, 56, 471-4.
12. TUBIANA M., KOSCIELNY S. - Natural history of breast cancer : Implications for a screening strategy. Int J Radiat Oncal Biol Phys, 1990, 19, 1117-20.
13. TUBIANA M. - Le dépistage du cancer du sein dans l'Union Européenne et la France. Bull Cancer, 1996, 83, 726-731.
14. ALLEMAND H. - Les critères de dépistage de masse des cancers. In : Bolla M. éd. Dépistage du cancer par les praticiens. Paris : Masson, 1993, 113-20.
15. BOLLA M. Dépistage du cancer par le praticien. Paris : Masson, 1993.
16. FAGNANI F., LE GALES C., LEFAURE C. - Analyse économique des cancers du sein par mammographie : comparaison des différentes organisations. J. Economic Médical, 1989, 5, 319-331.
17. LANCRY P.J., WAIT S. - Analyse économique des dépistages de masse du cancer du sein, Paris : Centre de recherche, d'étude et de documentation en économie de la santé, 1993.
18. ELLMAN R., ANGELI N., CHRISTIANS A., MOSS S., CHAMBERLAIN J., MAGUIRE P. - Psychiatric morbidity associated with screening for breast cancer. Br J Cancer, 1989, 60, 781-4.
19. GRAM I.T., SLENKER S.E. - Cancer anxiety and attitudes toward mammography among screening attenders, nonattenders, and women never invited. Am J Public Health, 1992, 82, 249-51.
20. SUTTON S., SAIDI G., HUNTER J. - Does routine screening for breast cancer raise anxiety ? Results from a three wave prospective study in England. J Epidemiol Community Health, 1995, 49, 413-8.
21. SCAF-KLOMP W., SANDERMAN R., VAN DE WIEL H.B.M. et al. - Distressed or relieved ? Psychological side effects of breast cancer screening in the Netherlands. J. Epidemiol. Community Health, 1997, 51, 705-710.
22. ELMORE J.G., BARTON M.B., MOCERI V.M.M., POLK S., ARENA P.Y., FLETCHER S.W. Ten-year risk of false positive screening mammograms and clinical breast examination. NewEngl. J. Med., 1998, 338, 1089-1096.
23. BERRINO F., BOUCHARDY C., SASCO A.J. - Screening for breast cancer in premenopausal women. Who should decider ? Int. J. Cancer, 1995, 60, 153-155.
24. TUBIANA M.- The European action against cancer. Cancer detection and prevention, 1993, 17 521-528.
25. WAIT S., ALLEMAND H. - The french breast cancer screening programme. Eur. J. Public Health, 1996, 6, 43-48.
26. DE WARD F., KIRKPATRICK A., PERRY N.M., TORNBERG A., TUBIANA M.- Breast cancer screening in the framework of Europe against cancer program. Eur J. Cancer Prevention, 1994, 3 (suppl 1), 3-5.
27. ANCELLE-PARK R., SERADOUR B., SCHAFFER P., ALLEMAND H., TUBIANA M. Le programme national de dépistage systématique des cancers du sein. Bull. Epidemiol. Hebdom., 1997, 10, 9-10.
28. MC CANN J., WAITS., SERADOUR B., DAYN. - A comparison of the performance and impact of breast cancer screening programme in East Anglia, UK and Bouche du Rhône France. Eur. J. Cancer, 1997, 33, 429-435.
29. WAIT S. - Le dépistage spontané du cancer du sein en France. Bull. Cancer, 1997, 87, 619-624.
30. European protocol on dosimetry in mammography (J. Zoetelief, M. Fitzzerald, W. Leitz, M. Satel) European commission. Eur 12263 FN, 1996.
31. Contrôle de qualité en mammographie - Protocole de contrôle de qualité des installations de mammographie - groupe technique (A. Noël, J. Desquerre-Aufort, A. Lisbona, C. Heid) 1998, Direction Générale de la Santé.